Endocrine oncology

1. Eur J Endocrinol15 May 2026

   Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice—an European Cooperative Study Group for Paediatric Rare Tumours survey

   Cross-sectional study

2. Thyroid14 May 2026

   TSH Stimulation Methods are Associated with Comparable Outcomes in Radioiodine-Avid Metastatic Differentiated Thyroid Cancer: Single Center Retrospective Observational Study

   Cohort study

3. Pituitary13 May 2026

   Clinicopathological features and outcomes of immature PIT-1 lineage tumors: A high-risk pituitary neuroendocrine tumor/pituitary adenoma subtype per WHO 2022

   Cohort study

4. Eur J Endocrinol12 May 2026

   18F-DOPA-PET/CT role in medullary thyroid cancer patients with biochemical incomplete response

   Diagnostic or prognostic study

5. Eur J Endocrinol7 May 2026

   Plasma proteomic profiling identifies apolipoprotein A4 as a downregulated biomarker of adrenocortical carcinoma: a multi-platform discovery and validation study

   Diagnostic or prognostic study

6. Eur Thyroid J6 May 2026

   CD8+ T cells in Hashimoto’s thyroiditis-associated papillary thyroid carcinoma

   Mechanistic study

7. Eur Thyroid J24 Apr 2026

   Assessing the sodium-iodide symporter (NIS) in pediatric differentiated thyroid carcinoma

   Cohort study

8. Eur Thyroid J24 Apr 2026

   Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer

   Cohort study

9. Eur Thyroid J22 Apr 2026

   Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer

   Meta-analysis

10. J Clin Endocrinol Metab22 Apr 2026

    The landscape of pediatric differentiated thyroid carcinoma and predictors of invasive disease: a CATC study

    Cohort study

11. Clin Endocrinol (Oxf)21 Apr 2026

    Procalcitonin Doubling Time for Postoperative Monitoring of Medullary Thyroid Carcinoma: A Comparative Kinetic Analysis

    Cohort study

12. J Clin Endocrinol Metab21 Apr 2026

    Outcome of first-line chemotherapy for anaplastic thyroid cancer—a multicenter registry analysis

    Cohort study

13. J Clin Endocrinol Metab17 Apr 2026

    Validation of the 2025 ATA risk stratification system in a cohort of patients with papillary thyroid carcinoma

    Cohort study

14. Eur J Endocrinol16 Apr 2026

    Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms

    Case-control study

15. Thyroid13 Apr 2026

    Real-World Efficacy and Safety of Lenvatinib and Sorafenib in Thyroid Cancer: A Retrospective, Propensity-Score-Matched Study

    Cohort study

16. Eur Thyroid J13 Apr 2026

    Real-world efficacy of lenvatinib/pembrolizumab combination in anaplastic thyroid carcinoma: case series from two Italian referral centers

    Cohort study

17. Thyroid13 Apr 2026

    Menopause-Related Health Outcomes in Women with Differentiated Thyroid Carcinoma Receiving Long-Term TSH Suppression after Total Thyroidectomy

    Cross-sectional study

18. Thyroid13 Apr 2026

    Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma

    Cohort study

19. Eur J Endocrinol11 Apr 2026

    Neuroendocrine tumors and pregnancy: the French PregNET study

    Cohort study

20. Thyroid9 Apr 2026

    A Temporal Analysis of Surgical Management and Outcomes Following ATA Guideline Updates in Papillary Thyroid Carcinoma: A Real-World Cohort Study of 31,861 Patients in South Korea

    Cohort study

21. Clin Endocrinol (Oxf)8 Apr 2026

    Brain Metastases in Differentiated Thyroid Carcinoma: Clinical Features, Treatment Outcomes, and the Role of Radioiodine Therapy

    Cohort study

22. Endocr Pract2 Apr 2026

    Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study

    Cross-sectional study

23. J Clin Endocrinol Metab27 Mar 2026

    Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment

    Cohort study

24. Eur J Endocrinol24 Mar 2026

    Quality of life questionnaire development and validation for adrenocortical carcinoma patients

    Diagnostic or prognostic study

25. Clin Endocrinol (Oxf)23 Mar 2026

    Comparative Analysis of Incidental and Non‐Incidental Papillary Thyroid Microcarcinoma Outcomes: Implications on Management Recommendations

    Cohort study

26. Eur Thyroid J23 Mar 2026

    Health-related quality of life with encorafenib plus binimetinib for BRAF V600E thyroid cancer

    Secondary analysis

27. Clin Endocrinol (Oxf)22 Mar 2026

    From Lobectomy to Completion Thyroidectomy: A Cohort Study and Systematic Review

    Meta-analysis

28. Eur Thyroid J20 Mar 2026

    Promise and pitfalls of AI chatbots in complex decision-making for thyroid nodules and papillary thyroid cancer

    Cross-sectional study

29. Thyroid17 Mar 2026

    The Patterns and Risk Factors for Antidepressant Drug Prescription in Thyroid Cancer Patients and Survivors: Analysis Based on the Korean National Health Insurance Service Database

    Cohort study

30. Eur Thyroid J13 Mar 2026

    Risk stratification and long-term monitoring in pediatric thyroid cancer: predictive markers for disease persistence

    Cohort study

31. Thyroid12 Mar 2026

    Patient-Reported Outcomes Three Years After Deciding on Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: Results of a Prospective Cohort Study

    Cohort study

32. Thyroid9 Mar 2026

    MarginView3D: Extending Novel 3D Surgical Pathology Reporting for Use in Invasive pT4 Thyroid Cancer and Other Surgical Oncologic Procedures

    Cohort study

33. Clin Endocrinol (Oxf)8 Mar 2026

    Effect of Radioactive Iodine Therapy on Cancer‐Specific Survival of Papillary Thyroid Carcinoma With T4aM0 Stage

    Cohort study

34. Eur J Endocrinol6 Mar 2026

    Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study

    Cohort study

35. Thyroid4 Mar 2026

    DNA Hypermethylation Suppresses Thyroid Peroxidase Expression and May Be a Promising Diagnostic Marker for Thyroid Cancer

    Mechanistic study

36. J Clin Endocrinol Metab4 Mar 2026

    Health-related quality of life in children with multiple endocrine neoplasia (MEN) and their siblings

    Cross-sectional study

37. J Clin Endocrinol Metab28 Feb 2026

    Time trends in incidence, treatment, and survival of patients with adrenocortical carcinoma, a nationwide study

    Cohort study

38. Thyroid27 Feb 2026

    Sexual Function and Depressive Symptoms in Premenopausal Women with Differentiated Thyroid Cancer: A Cross-Sectional Study

    Cross-sectional study

39. Endocr Pract26 Feb 2026

    Thermal Ablation Versus Thyroid Lobectomy for Subcapsular Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study

    Cohort study

40. Thyroid24 Feb 2026

    A Thyroid-Cancer-Specific Utility Index: Development and Valuation of the Thyroid Cancer Quality of Life Index

    Cross-sectional study

All 606 Briefs in ExploreShowing Briefs 41–80 of 606, newest first